- Senate passes Drug Quality and Security Act
- Cardinal Health invites independent pharmacy owners to ‘discover new horizons’ at RBC 2013
- Walgreens Infusion Services can save $10.8 million in healthcare costs annually
- MedFolio launches electronic pillbox to improve patient adherence
- Facing pharmacy trends for the remainder of the year
ARLINGTON, Va. — Building on its government affairs and public policy department, the National Association of Chain Drug Stores has hired Christopher Smith, formerly with the National Community Pharmacists Association, as director of federal public policy.
Smith will report to Kevin Nicholson, VP public policy and regulatory affairs. Smith started his new role with NACDS on Aug. 27.
The new director-level position will further enhance the scope of policy expertise within NACDS’ government affairs and public policy department, the Association stated.
In his role, Smith will provide policy guidance on pharmacy issues primarily at the federal level in the area of patient care, including Medicaid, medical homes, health exchanges and accountable care organizations. He will analyze and interpret policies and regulations that impact pharmacy patient care, prepare and deliver official testimony and comments, and serve as an authoritative resource on these issues for NACDS members.
“We are pleased to welcome Chris to the NACDS staff team,” stated NACDS president and CEO Steve Anderson. “His association and legislative experience, as well as his health policy law expertise will help further advance NACDS’ pro-patient, pro-pharmacy policy activities.”
Smith previously served as director of policy and regulatory affairs for NCPA, providing expertise on Medicare, Tricare and healthcare waste, fraud and abuse issues. In addition, he was a visiting assistant professor of law at Widener University School of Law’s Health Law Institute. Smith also conducted a fellowship with the U.S. Senate Judiciary Subcommittee on Crime and Drugs.
Get connected and follow us on LinkedIn for the most in-depth coverage of drug store news. Join the conversation.